Strengthening vaccination policies in Latin America: An evidence-based approach

Vaccine

Volumn 31, Issue 37, 2013, Pages 3826-3833

  Tapia Conyer, Roberto ^a   Betancourt Cravioto, Miguel ^a   Saucedo Martínez, Rodrigo ^a   Motta Murguía, Lourdes ^b   Gallardo Rincón, Héctor ^a  

^a Carlos Slim Health Institute   (Mexico)

^b PPAL Bureau of Public Affairs and Communication   (Mexico)

Author keywords

Immunisation; Latin America; Policy; Vaccination; Vaccine preventable disease; Vaccines

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; VACCINE; WART VIRUS VACCINE;

ADVISORY COMMITTEE; BCG VACCINATION; CHILD HEALTH; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DISEASE CONTROL; DISEASE SURVEILLANCE; DRUG COST; EVIDENCE BASED PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; IN SERVICE TRAINING; INFLUENZA VACCINATION; INTERNATIONAL COOPERATION; LARGE SCALE PRODUCTION; MEASLES VACCINATION; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; QUALITY CONTROL; REVIEW; SOUTH AND CENTRAL AMERICA; VACCINATION; WORLD HEALTH ORGANIZATION;

ACIP; ADVANCE MARKET COMMITMENT; AMC; CDC; CENTERS FOR DISEASE CONTROL; COFVAL; COMMISSION FOR THE FUTURE OF VACCINES IN LATIN AMERICA; DILAVAC; EMA; EPI; EUROPEAN MEDICINES AGENCY; EXPANDED PROGRAM ON IMMUNIZATION; IFFIM; IMMUNISATION; INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION; LATIN AMERICA; NATIONAL HEALTH ACCOUNTS; NATIONAL IMMUNISATION PROGRAMME; NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUPS; NATIONAL REGULATORY AGENCY; NHA; NIP; NITAG; NRA; OECD; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; PAHO; PAN AMERICAN HEALTH ORGANIZATION; PAN AMERICAN NETWORK ON DRUG REGULATORY HARMONIZATION; PANDRH; POLICY; R&D; RESEARCH AND DEVELOPMENT; VAC; VACCINATION; VACCINE ADVISORY COMMITTEE; VACCINE EUROPEAN NEW INTEGRATED COLLABORATION EFFORT; VACCINE-PREVENTABLE DISEASE; VACCINES; VENICE; VPD; WHO; WORLD HEALTH ORGANIZATION; [LATIN AMERICAN DIPLOMA ON VACCINOLOGY]; [U.S.] ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES;

ADVISORY COMMITTEES; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; IMMUNIZATION PROGRAMS; LATIN AMERICA; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; VACCINATION; VACCINES;

EID: 84881556083     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.062     Document Type: Review

References (76)

1. Pan American Health Organization Control of diptheria, pertussis, tetanus, influenzae type b and hepatitis B 2005, Pan American Health Organization, Washington, DC.
2. Castillo-Solorzano C., Marsigli C., Bravo-Alcantara P., Flannery B., Ruiz Matus C., Tambini G., et al. Elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis 2011, 204(September Suppl. (2)):S571-S578.
3. Pan American Health Organization. Introduction of Haemophilus influenzae type B vaccine in the America [cited 12.11.12]. Available from: http://www.paho.org/English/HVP/HVI/hvp_hib_text.htm.
4. Commission on the Future of Vaccines in Latin America. Strengthening vaccination policies in Latin America. D.F., Mexico: Instituto Carlos Slim de la Salud; 2008.
5. Duclos P., Ortynsky S., Abeysinghe N., Cakmak N., Janusz C.B., Jauregui B., et al. Monitoring of progress in the establishment and strengthening of national immunization technical advisory groups. Vaccine 2012, (April).
6. Centers for Disease Control. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2008. Morbidity and Mortality Weekly Report, 2008; 57(42):1148-51.
7. Fairbrother G., Freed G.L., Thompson J.W. Measuring immunization coverage. Am J Prev Med 2000, 19(October Suppl. (3)):78-88.
8. Ronveaux O., Rickert D., Hadler S., Groom H., Lloyd J., Bchir A., et al. The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems. Bull World Health Organ 2005, 83(July (7)):503-510.
9. Lozano R., Soliz P., Gakidou E., Abbott-Klafter J., Feehan D.M., Vidal C., et al. Benchmarking of performance of Mexican states with effective coverage. Lancet 2006, 368(November (9548)):1729-1741.
10. Hoang M.V., Nguyen T.B., Kim B.G., Dao L.H., Nguyen T.H., Wright P. Cost of providing the expanded programme on immunization: findings from a facility-based study in Viet Nam, 2005. Bull World Health Organ 2008, 86(June (6)):429-434.
11. Khaleghian P. Decentralization and public services: the case of immunization. Soc Sci Med 2004, 59(July (1)):163-183.
12. Dietz V., Venczel L., Izurieta H., Stroh G., Zell E.R., Monterroso E., et al. Assessing and monitoring vaccination coverage levels: lessons from the Americas. Rev Panam Salud Publica 2004, 16(December (6)):432-442.
13. Bennett S., Woods T., Liyanage W.M., Smith D.L. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 1991, 44(3):98-106.
14. Frerichs R.R., Shaheen M.A. Small-community-based surveys. Ann Rev Public Health 2001, 22:231-247.
15. Frerichs R.R., Tar K.T. Computer-assisted rapid surveys in developing countries. Public Health Rep 1989, 104(January-February (1)):14-23.
16. Lemeshow S., Robinson D. Surveys to measure programme coverage and impact: a review of the methodology used by the expanded programme on immunization. World Health Stat Q 1985, 38(1):65-75.
17. World Health Organization Immunization coverage cluster survey - reference manual 2005, World Health Organization, Geneva, Switzerland.
18. Castillo-Solorzano C., Andrus J., Periago M.R. [Development of new vaccines: information production for decision making]. Rev Panam Salud Publica 2004, 15(January (1)):1-3.
19. Barclay E. Predicting the next pandemic. Lancet 2008, 372(September (9643)):1025-1026.
20. World Health Organization. National health accounts. Updated 2012 [cited 16.07.12]. Available from: http://www.who.int/nha/what/en/index.html.
21. Morgan D. Implementation of the system of health accounts in OECD countries. 2005 [cited 17.07.12]. Available from: http://www.oecd.org/dataoecd/25/36/35981290.pdf.
22. OECD, World Health Organization, Eurostat A System of health accounts 2011, World Health Organization.
23. de Quadros C.C.A., Olive J.-M., Nogueira C., Carrasco P., Silveira C. Expanded program on immunization (EPI). Maternal and Child health activities at the local level: towards the goals of the world summit for children 1998, Pan American Health Organization, 141-170. Y. Benguigui, S. Land, J.M. Paganini, J. Yunes (Eds.).
24. Victora C.G., Wagstaff A., Schellenberg J.A., Gwatkin D., Claeson M., Habicht J.P. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet 2003, 362(July (9379)):233-241.
25. Antunes J.L., Waldman E.A., Borrell C., Paiva T.M. Effectiveness of influenza vaccination and its impact on health inequalities. Int J Epidemiol 2007, 36(December (6)):1319-1326.
26. Backman G., Hunt P., Khosla R., Jaramillo-Strouss C., Fikre B.M., Rumble C., et al. Health systems and the right to health: an assessment of 194 countries. Lancet 2008, 372(December (9655)):2047-2085.
27. Vaccine European New Integrated Collaboration Effort. VENICE II - The Project. Available from: http://venice.cineca.org/the_project.html.
28. Pan American Health Organization Introduction and implementation of new vaccines 2010, Field Guide.
29. de la Hoz F., Perez L., Wheeler J.G., de Neira M., Hall A.J. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage?. Trop Med Int Health 2005, 10(April (4)):322-329.
30. Kennedy A., Groom H., Evans V., Fasano N. A qualitative analysis of immunization programs with sustained high coverage 2000-2005. J Public Health Manag Pract 2010, 16(January-February (1)):E9-E17.
31. Kimmel S.R., Burns I.T., Wolfe R.M., Zimmerman R.K. Addressing immunization barriers, benefits, and risks. J Fam Pract 2007, 56(February Suppl. (2 vaccines)):S61-S69.
32. Ortega Molina P., Astasio Arbiza P., Albaladejo Vicente R., Arrazola Martinez P., Villanueva Orbaiz R., Ramon de Juanes Pardo J. Cold chain maintenance in vaccines: a systematic review. Gac Sanit 2007, 21(July-August (4)):343-348.
33. World Health Organization Proper handling and reconstitution of vaccines avoids programme errors; 2000.
34. Gust D.A., Kennedy A., Shui I., Smith P.J., Nowak G., Pickering L.K. Parent attitudes toward immunizations and healthcare providers the role of information. Am J Prev Med 2005, 29(August (2)):105-112.
35. Schmitt H.J., Booy R., Aston R., Van Damme P., Schumacher R.F., Campins M., et al. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 2007, 5:11.
36. PATH. Andhra Pradesh Building a model immunization system. 2004 [cited 17.07.12]. Available from: http://www.path.org/vaccineresources/files/CVP_AP.pdf.
37. World Health Organization. Mid-level management training in immunization in the African region 2000-2004. 2004 [cited 17.07.12]. Available from: http://www.who.int/immunization_training/reports/MLM%20course%20Evaluation_final.pdf.
38. Carlos Slim Health Institute. Diplomado Latinoamericano de Vacunología (DILAVAC) updated 2010 [cited 20.07.12]. Available from: http://www.salud.carlosslim.org/SoluGlob/Paginas/vacuPage.aspx.
39. Pan American Health Organization Immunization in the Americas: 2011 summary 2011, Pan American Health Organization, Washington, DC.
40. Smith J.C., Snider D.E., Pickering L.K. Immunization policy development in the United States: the role of the advisory committee on immunization practices. Ann Intern Med 2009, 150(January (1)):45-49.
41. Advisory Committee on Immunization Practices. General committee-related information. Updated August, 2012 [cited 16.08.12]. Available from: http://www.cdc.gov/vaccines/recs/ACIP/.
42. Ahmed F., Temte J.L., Campos-Outcalt D., Schunemann H.J. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2011, 29(November (49)):9171-9176.
43. Advisory Committee on Immunization Practices Recommended adult immunization schedule: United States. Ann Intern Med 2012, 156(Feb (3)):211-217.
44. Advisory Committee on Immunization Practices Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Weekly Rep 2010, 59(September (34)):1102-1106.
45. World Health Organization Adding a vaccine to a national immunization programme: decision and implementation 2005, World Health Organization, Geneva, Switzerland.
46. Pan American Health Organization. ProVac. Updated March, 2012 [cited 18.07.12]. Available from: http://new.paho.org/provac/index.php?option=com_frontpage&Itemid=1.
47. Andrus J.K., Toscano C.M., Lewis M., Oliveira L., Ropero A.M., Davila M., et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Rep 2007, 122(November-December (6)):811-816.
48. Centers for Disease Control. CoCASA (Comprehensive Clinic Assessment Software Application). Updated May, 2012 [cited 18.07.12]. Available from: http://www.cdc.gov/vaccines/programs/cocasa/index.html.
49. Pan American Health Organization. PAHO Revolving Fund. Updated August, 2011 [cited 18.07.12]. Available from: http://www.paho.org/english/hvp/hvi/revol_fund.htm.
50. DeRoeck D., Bawazir S.A., Carrasco P., Kaddar M., Brooks A., Fitzsimmons J., et al. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. Int J Health Plann Manage 2006, 21(January-March (1)):23-43.
51. Pan American Health Organization Operating Procedures of the PAHO Revolving Fund for the purchase of vaccines syringes and other related supplies 2012, Pan American Health Organization, Washington, DC.
52. Pan American Health Organization Operating procedures of the PAHO Revolving Fund for the purchase of vaccines, syringes and other related supplies 2011, Pan American Health Organization, Washington, DC.
53. Giaccotto C., Santerre R.E., Vernon J.A. Drug prices and research and development investment behavior in the pharmaceutical industry. Journal of Law and Economics 2005, 48(1):195-214.
54. Berndt E.R., Hurvitz J.A. Vaccine advance-purchase agreements for low-income countries: practical issues. Health Aff (Millwood) 2005, 24(May-June (3)):653-665.
55. Berndt E.R., Glennerster R., Kremer M.R., Lee J., Levine R., Weizsacker G., et al. Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness. Health Econ 2007, 16(May (5)):491-511.
56. Snyder C.M., Begor W., Berndt E.R. Economic perspectives on the advance market commitment for pneumococcal vaccines. Health Aff (Millwood) 2011, 30(August (8)):1508-1517.
57. Cernuschi T., Furrer E., Schwalbe N., Jones A., Berndt E.R., McAdams S. Advance market commitment for pneumococcal vaccines: putting theory into practice. Bull World Health Organ 2011, 89(December (12)):913-918.
58. Braine T. Controversial funding mechanism to fight pneumonia. Bull World Health Organ 2008, 86(May (5)):325-326.
59. Atkinson A.B. New sources of development finance: funding the milenium development goals 2004, United Nations University, Helsinki, Finland.
60. Barder O., Yeh E. The costs and benefits of front-loading and the predictability of immunization 2006.
61. GAVI: Development loans for immunization. Geneva, Switzerland; 2002.
62. Milstien J., Belgharbi L. Regulatory pathways for vaccines for developing countries. Bull World Health Organ 2004, 82(February (2)):128-133.
63. World Health Organization Regulation of vaccines: building on existing drug regulatory authorities 1999, World Health Organization, Geneva, Switzerland.
64. Pan American Health Organization. System for Evaluation of the National Regulatory Authorities for Medicines. Updated November, 2010 [cited 16.08.12]. Available from: http://new.paho.org/hq/index.php?option=com_content&task=view&id=1615&Itemid=1179&lang=en.
65. Pan American Network on Drug Regulatory Harmonization Harmonized requirements for the licensing of vaccines in the americas and guidelines for preparation of application 2008, PAHO, Washington, DC.
66. Mahoney R.T., Maynard J.E. The introduction of new vaccines into developing countries. Vaccine 1999, 17(February (7-8)):646-652.
67. Hotez P.J., Ferris M.T. The antipoverty vaccines. Vaccine 2006, 24(July (31-32)):5787-5799.
68. Commission on Macroeconomics Health Macroeconomics and health: investing in health for economic development 2001, Commission on Macroeconomics and Health, Geneva, Switzerland.
69. Danzon P.M., Nicholson S., Sousa Pereira N. Productivity in pharmaceutical biotechnology R&D: the role of experiences and alliances 2003, National Bureau of Economic Research, Cambridge, MA.
70. Sabin Vaccine Institute. Sabin Vaccine Institute PDP. Updated 2012 [19.07.12]. Available from: http://www.sabin.org/vaccine-development.
71. Bottazzi M.E., Brown A.S. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm. Expert Rev Vaccines 2008, 7(December (10)):1481-1492.
72. Bottazzi M.E., Miles A.P., Diemert D., Hotez P.J. An ounce of prevention on a budget: a non-profit approach to developing vaccines against neglected diseases. Expert Rev Vaccines 2006, 5(April (2)):189-198.
73. Bottazzi M.E., Dumonteil E., Valenzuela J.G., Betancourt-Cravioto M., Tapia-Conyer R., Hotez P.J. Bridging the innovation gap for neglected tropical diseases in Mexico: capacity building for the development of a new generation of antipoverty vaccines. Bolétin médico del Hospital Infantil de México 2011, 68(2):138-146.
74. Morel C.M., Acharya T., Broun D., Dangi A., Elias C., Ganguly N.K., et al. Health innovation networks to help developing countries address neglected diseases. Science 2005, 309(July (5733)):401-404.
75. Possani L.D. The past, present, and future of biotechnology in Mexico. Nat Biotechnol 2003, 21(May (5)):582-583.
76. Tristao I, Inter-American Development Bank. Perfiles de salud de los paises de Mesoamerica [Health profiles of Mesoamerican countries]. Washington, DC; 2009.